Gene-IT Changes Company Name To GenomeQuest, Inc.
WESTBOROUGH, Mass.--Gene-IT, a leader in sequence search, today announced that the company is changing its name to GenomeQuest, Inc., taking its new name from its flagship, industry-leading IP and biological sequence search solution, GenomeQuest(TM).
Ronald Ranauro, President and CEO of GenomeQuest, Inc., said, "We think the GenomeQuest(TM) brand nicely communicates to our customers our product vision and our core company mission, which is to enable researchers to use search technology to organize and render the world's genetic sequence data and make it easy to access for a broad range of end-users."
Dr. Michael J. McManus, Vice President and General Manager of GenomeQuest, Inc., added, "As a company, it is clear that we are the leader in IP sequence search in the industry. From that perspective, uniting our product and company names is a natural evolution for our business - which our clients depend on for trustworthy, timely, and high-quality information that leads them to better decision-making about IP."
GenomeQuest(TM) is a sequence search solution that enables biologists to evaluate novel gene sequences, and allows IP lawyers to evaluate freedom-to-operate, patentability, and competitive landscape features for the same sequences. The solution uniquely combines easy-to-use sequence search and analytics with public and proprietary sequence content, including the industry's largest and most complete indexed archive of more than 40 million patented sequences.
About GenomeQuest, Inc.
GenomeQuest Inc.'s innovative sequence search technology provides relevant answers to questions about the human genome asked by scientists and attorneys today. The company's flagship product, GenomeQuest(TM), is an easy-to-use Web-based application that integrates, mines and analyzes sequence data from dozens of scientific and patent sources worldwide. GenomeQuest's proprietary sequence analysis capabilities help the world's leading pharmaceutical and biotechnology companies make faster and more accurate decisions on their gene and protein discoveries. Its automated alerting, report publishing and knowledge-sharing capabilities enhance the productivity of all users. GenomeQuest, Inc. is headquartered in Westborough, Massachusetts. For more information, please call (508) 616-0100, or visit our web site: www.genomequest.com.
Contacts
Aviator PR
Mario Fante, 617-763-9887
mario@aviator-pr.com
Ronald Ranauro, President and CEO of GenomeQuest, Inc., said, "We think the GenomeQuest(TM) brand nicely communicates to our customers our product vision and our core company mission, which is to enable researchers to use search technology to organize and render the world's genetic sequence data and make it easy to access for a broad range of end-users."
Dr. Michael J. McManus, Vice President and General Manager of GenomeQuest, Inc., added, "As a company, it is clear that we are the leader in IP sequence search in the industry. From that perspective, uniting our product and company names is a natural evolution for our business - which our clients depend on for trustworthy, timely, and high-quality information that leads them to better decision-making about IP."
GenomeQuest(TM) is a sequence search solution that enables biologists to evaluate novel gene sequences, and allows IP lawyers to evaluate freedom-to-operate, patentability, and competitive landscape features for the same sequences. The solution uniquely combines easy-to-use sequence search and analytics with public and proprietary sequence content, including the industry's largest and most complete indexed archive of more than 40 million patented sequences.
About GenomeQuest, Inc.
GenomeQuest Inc.'s innovative sequence search technology provides relevant answers to questions about the human genome asked by scientists and attorneys today. The company's flagship product, GenomeQuest(TM), is an easy-to-use Web-based application that integrates, mines and analyzes sequence data from dozens of scientific and patent sources worldwide. GenomeQuest's proprietary sequence analysis capabilities help the world's leading pharmaceutical and biotechnology companies make faster and more accurate decisions on their gene and protein discoveries. Its automated alerting, report publishing and knowledge-sharing capabilities enhance the productivity of all users. GenomeQuest, Inc. is headquartered in Westborough, Massachusetts. For more information, please call (508) 616-0100, or visit our web site: www.genomequest.com.
Contacts
Aviator PR
Mario Fante, 617-763-9887
mario@aviator-pr.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.